The self-controlled case series method for evaluating safety of vaccines

Steven Hawken and Kumanan R Wilson
Med J Aust 2012; 197 (10): . || doi: 10.5694/mja12.11087
Published online: 19 November 2012

Using cases as their own controls potentially provides stronger evidence for analysing adverse events following vaccination

Maintaining public confidence in vaccines requires having effective postmarketing vaccine safety surveillance systems in place to rapidly address emerging concerns about vaccine safety. However, conducting studies of vaccine safety presents several challenges for traditional observational study designs. Important differences may exist between vaccinated and unvaccinated individuals that could confound the true association of interest between vaccination and adverse events. In practice, it is often difficult or impossible to adequately control statistically for these differences, either because confounders are unmeasured or unmeasureable, or because of the scarcity of unvaccinated controls when studying population-wide immunisation programs.

  • Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.


Competing interests:

No relevant disclosures.

  • 1. Crawford NW, Cheng A, Andrews N, et al. Guiilain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Med J Aust 2012; 197: 574-578.
  • 2. Andrews NJ. Statistical assessment of the association between vaccination and rare adverse events post-licensure. Vaccine 2001; 20 Suppl 1: S49-S53.
  • 3. Farrington CP. Control without separate controls: evaluation of vaccine safety using case-only methods. Vaccine 2004; 22: 2064-2070.
  • 4. Farrington CP, Pugh S, Colville A, et al. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet 1995; 345: 567-569.
  • 5. Whitaker HJ, Farrington CP, Spiessens B, Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006; 25: 1768-1797.
  • 6. Weldeselassie YG, Whitaker HJ, Farrington CP. Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice. Epidemiol Infect 2011; 139: 1805-1817.
  • 7. Virtanen M, Peltola H, Paunio M, Heinonen OP. Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics 2000; 106: E62.
  • 8. Wilson K, Hawken S, Potter BK, et al. Patterns of emergency room visits, admissions and death following recommended pediatric vaccinations - a population based study of 969,519 vaccination events. Vaccine 2011; 29: 3746-3752.
  • 9. Farrington CP, Whitaker HJ, Hocine MN. Case series analysis for censored, perturbed, or curtailed post-event exposures. Biostatistics 2009; 10: 3-16.
  • 10. Kuhnert R, Hecker H, Poethko-Müller C, et al. A modified self-controlled case series method to examine association between multidose vaccinations and death. Stat Med 2010; 30: 666-677.
  • 11. Farrington CP, Whitaker HJ. Semiparametric analysis of case series data. J R Stat Soc Ser C Appl Stat 2006; 55: 553-594.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.